Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke
BACKGROUND AND PURPOSE—Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive Status (TICS) and the Telephone Montreal Cognitive Assessment (T-MoCA) are considered useful screening instruments. Yet, e...
Saved in:
Published in | Stroke (1970) Vol. 48; no. 11; pp. 2952 - 2957 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.11.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0039-2499 1524-4628 1524-4628 |
DOI | 10.1161/STROKEAHA.117.017519 |
Cover
Loading…
Abstract | BACKGROUND AND PURPOSE—Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive Status (TICS) and the Telephone Montreal Cognitive Assessment (T-MoCA) are considered useful screening instruments. Yet, evidence to define optimal cut-offs for mild cognitive impairment (MCI) after stroke is limited.
METHODS—We studied 105 patients enrolled in the prospective DEDEMAS study (Determinants of Dementia After Stroke; NCT01334749). Follow-up visits at 6, 12, 36, and 60 months included comprehensive neuropsychological testing and the Clinical Dementia Rating scale, both of which served as reference standards. The original TICS and T-MoCA were obtained in 2 separate telephone interviews each separated from the personal visits by 1 week (1 before and 1 after the visit) with the order of interviews (TICS versus T-MoCA) alternating between subjects. Area under the receiver-operating characteristic curves was determined.
RESULTS—Ninety-six patients completed both the face-to-face visits and the 2 interviews. Area under the receiver-operating characteristic curves ranged between 0.76 and 0.83 for TICS and between 0.73 and 0.94 for T-MoCA depending on MCI definition. For multidomain MCI defined by multiple-tests definition derived from comprehensive neuropsychological testing optimal sensitivities and specificities were achieved at cut-offs <36 (TICS) and <18 (T-MoCA). Validity was lower using single-test definition, and cut-offs were higher compared with multiple-test definitions. Using Clinical Dementia Rating as the reference, optimal cut-offs for MCI were <36 (TICS) and approximately 19 (T-MoCA).
CONCLUSIONS—Both the TICS and T-MoCA are valid screening tools poststroke, particularly for multidomain MCI using multiple-test definition. |
---|---|
AbstractList | Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive Status (TICS) and the Telephone Montreal Cognitive Assessment (T-MoCA) are considered useful screening instruments. Yet, evidence to define optimal cut-offs for mild cognitive impairment (MCI) after stroke is limited.
We studied 105 patients enrolled in the prospective DEDEMAS study (Determinants of Dementia After Stroke; NCT01334749). Follow-up visits at 6, 12, 36, and 60 months included comprehensive neuropsychological testing and the Clinical Dementia Rating scale, both of which served as reference standards. The original TICS and T-MoCA were obtained in 2 separate telephone interviews each separated from the personal visits by 1 week (1 before and 1 after the visit) with the order of interviews (TICS versus T-MoCA) alternating between subjects. Area under the receiver-operating characteristic curves was determined.
Ninety-six patients completed both the face-to-face visits and the 2 interviews. Area under the receiver-operating characteristic curves ranged between 0.76 and 0.83 for TICS and between 0.73 and 0.94 for T-MoCA depending on MCI definition. For multidomain MCI defined by multiple-tests definition derived from comprehensive neuropsychological testing optimal sensitivities and specificities were achieved at cut-offs <36 (TICS) and <18 (T-MoCA). Validity was lower using single-test definition, and cut-offs were higher compared with multiple-test definitions. Using Clinical Dementia Rating as the reference, optimal cut-offs for MCI were <36 (TICS) and approximately 19 (T-MoCA).
Both the TICS and T-MoCA are valid screening tools poststroke, particularly for multidomain MCI using multiple-test definition. BACKGROUND AND PURPOSE—Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive Status (TICS) and the Telephone Montreal Cognitive Assessment (T-MoCA) are considered useful screening instruments. Yet, evidence to define optimal cut-offs for mild cognitive impairment (MCI) after stroke is limited. METHODS—We studied 105 patients enrolled in the prospective DEDEMAS study (Determinants of Dementia After Stroke; NCT01334749). Follow-up visits at 6, 12, 36, and 60 months included comprehensive neuropsychological testing and the Clinical Dementia Rating scale, both of which served as reference standards. The original TICS and T-MoCA were obtained in 2 separate telephone interviews each separated from the personal visits by 1 week (1 before and 1 after the visit) with the order of interviews (TICS versus T-MoCA) alternating between subjects. Area under the receiver-operating characteristic curves was determined. RESULTS—Ninety-six patients completed both the face-to-face visits and the 2 interviews. Area under the receiver-operating characteristic curves ranged between 0.76 and 0.83 for TICS and between 0.73 and 0.94 for T-MoCA depending on MCI definition. For multidomain MCI defined by multiple-tests definition derived from comprehensive neuropsychological testing optimal sensitivities and specificities were achieved at cut-offs <36 (TICS) and <18 (T-MoCA). Validity was lower using single-test definition, and cut-offs were higher compared with multiple-test definitions. Using Clinical Dementia Rating as the reference, optimal cut-offs for MCI were <36 (TICS) and approximately 19 (T-MoCA). CONCLUSIONS—Both the TICS and T-MoCA are valid screening tools poststroke, particularly for multidomain MCI using multiple-test definition. Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive Status (TICS) and the Telephone Montreal Cognitive Assessment (T-MoCA) are considered useful screening instruments. Yet, evidence to define optimal cut-offs for mild cognitive impairment (MCI) after stroke is limited.BACKGROUND AND PURPOSEAssessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive Status (TICS) and the Telephone Montreal Cognitive Assessment (T-MoCA) are considered useful screening instruments. Yet, evidence to define optimal cut-offs for mild cognitive impairment (MCI) after stroke is limited.We studied 105 patients enrolled in the prospective DEDEMAS study (Determinants of Dementia After Stroke; NCT01334749). Follow-up visits at 6, 12, 36, and 60 months included comprehensive neuropsychological testing and the Clinical Dementia Rating scale, both of which served as reference standards. The original TICS and T-MoCA were obtained in 2 separate telephone interviews each separated from the personal visits by 1 week (1 before and 1 after the visit) with the order of interviews (TICS versus T-MoCA) alternating between subjects. Area under the receiver-operating characteristic curves was determined.METHODSWe studied 105 patients enrolled in the prospective DEDEMAS study (Determinants of Dementia After Stroke; NCT01334749). Follow-up visits at 6, 12, 36, and 60 months included comprehensive neuropsychological testing and the Clinical Dementia Rating scale, both of which served as reference standards. The original TICS and T-MoCA were obtained in 2 separate telephone interviews each separated from the personal visits by 1 week (1 before and 1 after the visit) with the order of interviews (TICS versus T-MoCA) alternating between subjects. Area under the receiver-operating characteristic curves was determined.Ninety-six patients completed both the face-to-face visits and the 2 interviews. Area under the receiver-operating characteristic curves ranged between 0.76 and 0.83 for TICS and between 0.73 and 0.94 for T-MoCA depending on MCI definition. For multidomain MCI defined by multiple-tests definition derived from comprehensive neuropsychological testing optimal sensitivities and specificities were achieved at cut-offs <36 (TICS) and <18 (T-MoCA). Validity was lower using single-test definition, and cut-offs were higher compared with multiple-test definitions. Using Clinical Dementia Rating as the reference, optimal cut-offs for MCI were <36 (TICS) and approximately 19 (T-MoCA).RESULTSNinety-six patients completed both the face-to-face visits and the 2 interviews. Area under the receiver-operating characteristic curves ranged between 0.76 and 0.83 for TICS and between 0.73 and 0.94 for T-MoCA depending on MCI definition. For multidomain MCI defined by multiple-tests definition derived from comprehensive neuropsychological testing optimal sensitivities and specificities were achieved at cut-offs <36 (TICS) and <18 (T-MoCA). Validity was lower using single-test definition, and cut-offs were higher compared with multiple-test definitions. Using Clinical Dementia Rating as the reference, optimal cut-offs for MCI were <36 (TICS) and approximately 19 (T-MoCA).Both the TICS and T-MoCA are valid screening tools poststroke, particularly for multidomain MCI using multiple-test definition.CONCLUSIONSBoth the TICS and T-MoCA are valid screening tools poststroke, particularly for multidomain MCI using multiple-test definition. |
Author | Müller, Claudia Zietemann, Vera Wollenweber, Frank Arne Kopczak, Anna Dichgans, Martin |
AuthorAffiliation | From the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany (V.Z., A.K., C.M., A.W., M.D.); German Center for Neurodegenerative Diseases (DZNE), Munich, Germany (M.D.); and Munich Cluster for Systems Neurology (SyNergy), Germany (M.D.) |
AuthorAffiliation_xml | – name: From the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany (V.Z., A.K., C.M., A.W., M.D.); German Center for Neurodegenerative Diseases (DZNE), Munich, Germany (M.D.); and Munich Cluster for Systems Neurology (SyNergy), Germany (M.D.) |
Author_xml | – sequence: 1 givenname: Vera surname: Zietemann fullname: Zietemann, Vera organization: From the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany (V.Z., A.K., C.M., A.W., M.D.); German Center for Neurodegenerative Diseases (DZNE), Munich, Germany (M.D.); and Munich Cluster for Systems Neurology (SyNergy), Germany (M.D.) – sequence: 2 givenname: Anna surname: Kopczak fullname: Kopczak, Anna – sequence: 3 givenname: Claudia surname: Müller fullname: Müller, Claudia – sequence: 4 givenname: Frank surname: Wollenweber middlename: Arne fullname: Wollenweber, Frank Arne – sequence: 5 givenname: Martin surname: Dichgans fullname: Dichgans, Martin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29042492$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhS1URKeFN0AoSzYp_k1idtG00BGtKtGBbeRJbmZMHXtqOx3xiLwVnqZUIxYgL6xrf-feq3NO0JF1FhB6S_AZIQX5cLv8evPlor6sU1meYVIKIl-gGRGU57yg1RGaYcxkTrmUx-gkhB8YY8oq8QodU4l5eqcz9Ou7MrpTUTubuT6LG8iWYGC7ScOyhY3gHzTs9l9zt7Y66gfIbqOKY8iU7Q7Ya2ejB2UOuDoECGEAG7N6rbQNMTuHqLSB7oBaQojarh_bzY22uk1NzrVaWxd02E--1uZQsBi2SvupbZ8WTPt4dwev0ctemQBvnu5T9O3TxXJ-mV_dfF7M66u85ZjKXPVVK3tSYFF1ybOiKHnX85KsGClZcpIJobgkTJZdyyqKBVeS99WqVCxRVctO0fup79a7-zEt3ww6tGCMsuDG0BApaDpClgl994SOqwG6Zuv1oPzP5o_9CeAT0HoXgof-GSG42afcPKecyrKZUk6yj3_JWh0fM4w-2fs_cTWJd84k98KdGXfgm03KLm7-Lf0NA1fCPA |
CitedBy_id | crossref_primary_10_1161_STROKEAHA_117_018828 crossref_primary_10_1053_j_jvca_2023_04_035 crossref_primary_10_3389_fstro_2023_1190477 crossref_primary_10_1136_bmjopen_2024_092611 crossref_primary_10_1002_alz_12569 crossref_primary_10_1177_23969873211042192 crossref_primary_10_1007_s40520_021_01886_z crossref_primary_10_3390_jpm11080688 crossref_primary_10_1016_j_jcomdis_2021_106144 crossref_primary_10_1159_000521903 crossref_primary_10_1097_ALN_0000000000003650 crossref_primary_10_3389_fphar_2022_803903 crossref_primary_10_1093_arclin_acad066 crossref_primary_10_3389_fpsyt_2022_899729 crossref_primary_10_1002_jcsm_13264 crossref_primary_10_1080_17483107_2025_2459324 crossref_primary_10_1177_20542704221115956 crossref_primary_10_34250_jkccn_2020_13_3_75 crossref_primary_10_1111_jgs_17190 crossref_primary_10_1001_jamasurg_2018_5093 crossref_primary_10_1016_j_pmr_2023_06_028 crossref_primary_10_1001_jamaneurol_2022_2262 crossref_primary_10_1111_ene_15068 crossref_primary_10_1002_dad2_12144 crossref_primary_10_1002_alz_13039 crossref_primary_10_1016_j_jcrc_2019_04_028 crossref_primary_10_1177_02692155221129834 crossref_primary_10_1080_13854046_2021_1933190 crossref_primary_10_1186_s12877_022_03160_x crossref_primary_10_1016_j_cct_2023_107137 crossref_primary_10_1080_13825585_2023_2189688 crossref_primary_10_3390_jcm11092637 crossref_primary_10_1016_j_neuarg_2022_12_001 crossref_primary_10_1186_s13063_021_05879_1 crossref_primary_10_1007_s11060_023_04303_9 crossref_primary_10_1016_j_iccn_2023_103605 crossref_primary_10_1016_j_jagp_2023_04_007 crossref_primary_10_1111_jgs_17318 crossref_primary_10_1136_bmjopen_2023_075015 crossref_primary_10_1016_j_clineuro_2019_105657 crossref_primary_10_1002_dad2_12410 crossref_primary_10_2139_ssrn_4113935 crossref_primary_10_1093_arclin_acaa096 crossref_primary_10_3390_biomedicines9020223 crossref_primary_10_1002_alz_12197 crossref_primary_10_1097_WNP_0000000000001146 crossref_primary_10_1007_s11764_023_01371_8 crossref_primary_10_1177_08919887211002640 crossref_primary_10_1177_01939459231220283 crossref_primary_10_1590_1980_5764_dn_2023_0020 crossref_primary_10_3390_jcm11226653 crossref_primary_10_1186_s12883_020_01903_0 crossref_primary_10_3389_fcvm_2022_896846 crossref_primary_10_1080_13854046_2020_1801848 crossref_primary_10_9778_cmajo_20220248 crossref_primary_10_1186_s13054_021_03856_3 crossref_primary_10_1016_j_jclinane_2024_111576 crossref_primary_10_1002_14651858_CD013724_pub2 crossref_primary_10_1016_j_wneu_2023_02_005 crossref_primary_10_1080_23279095_2021_1908287 crossref_primary_10_1136_bmjopen_2022_064517 crossref_primary_10_3390_ijerph20032699 crossref_primary_10_12688_openreseurope_15005_1 crossref_primary_10_1002_mds_28763 crossref_primary_10_1155_2022_9540701 |
Cites_doi | 10.1002/gps.930091006 10.1017/S003329170002691X 10.1186/s12916-017-0779-7 10.1016/S1474-4422(16)00130-7 10.1161/STROKEAHA.112.673384 10.1161/STROKEAHA.111.633586 10.1016/S1474-4422(09)70236-4 10.1161/STR.0b013e3182299496 10.1161/STROKEAHA.114.005842 10.1111/ijs.12092 10.1001/archneur.58.3.397 10.1159/000355496 10.1212/WNL.0b013e31820ce6a5 10.1371/journal.pone.0122864 10.1212/WNL.43.11.2412-a 10.1161/CIRCRESAHA.116.308426 10.1017/S1355617716000199 10.1002/gps.1041 10.1161/01.STR.0000237236.88823.47 10.1161/STROKEAHA.114.004232 10.1159/000447057 |
ContentType | Journal Article |
Copyright | 2017 American Heart Association, Inc. |
Copyright_xml | – notice: 2017 American Heart Association, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/STROKEAHA.117.017519 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4628 |
EndPage | 2957 |
ExternalDocumentID | 29042492 10_1161_STROKEAHA_117_017519 10.1161/STROKEAHA.117.017519 |
Genre | Validation Studies Multicenter Study Clinical Trial Journal Article |
GroupedDBID | --- .3C .55 .GJ .XZ .Z2 01R 0R~ 123 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 71W 77Y 7O~ A9M AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AAUEB AAXQO AAYEP AAYJJ ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFS ACGOD ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BCGUY BOYCO BQLVK BS7 C45 CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B M18 N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YQJ YYP ZB8 ZGI ZZMQN AAYXX ADGHP CITATION ACIJW AWKKM CGR CUY CVF ECM EIF NPM OJAPA OLW RHF YCJ 7X8 ADSXY |
ID | FETCH-LOGICAL-c4029-af8c9f16058d1756674df471b3173117355a491397dc382054a94f8b7a34718c3 |
ISSN | 0039-2499 1524-4628 |
IngestDate | Fri Sep 05 03:25:40 EDT 2025 Wed Feb 19 02:43:01 EST 2025 Tue Jul 01 03:31:53 EDT 2025 Thu Apr 24 22:53:18 EDT 2025 Fri May 16 03:42:47 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | mild cognitive impairment ROC curve Telephone Montreal Cognitive Assessment stroke Telephone Interview of Cognitive Status validation |
Language | English |
License | 2017 American Heart Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4029-af8c9f16058d1756674df471b3173117355a491397dc382054a94f8b7a34718c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.117.017519 |
PMID | 29042492 |
PQID | 1952525597 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1952525597 pubmed_primary_29042492 crossref_primary_10_1161_STROKEAHA_117_017519 crossref_citationtrail_10_1161_STROKEAHA_117_017519 wolterskluwer_health_10_1161_STROKEAHA_117_017519 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-November 2017-11-00 2017-Nov 20171101 |
PublicationDateYYYYMMDD | 2017-11-01 |
PublicationDate_xml | – month: 11 year: 2017 text: 2017-November |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Stroke (1970) |
PublicationTitleAlternate | Stroke |
PublicationYear | 2017 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_4_3_2 e_1_3_4_2_2 e_1_3_4_9_2 e_1_3_4_8_2 e_1_3_4_7_2 Brandt J (e_1_3_4_10_2) 1988; 1 e_1_3_4_6_2 e_1_3_4_5_2 e_1_3_4_4_2 e_1_3_4_11_2 e_1_3_4_22_2 e_1_3_4_12_2 e_1_3_4_23_2 e_1_3_4_20_2 e_1_3_4_21_2 e_1_3_4_15_2 e_1_3_4_16_2 e_1_3_4_13_2 e_1_3_4_14_2 e_1_3_4_19_2 e_1_3_4_17_2 e_1_3_4_18_2 |
References_xml | – ident: e_1_3_4_11_2 doi: 10.1002/gps.930091006 – ident: e_1_3_4_16_2 doi: 10.1017/S003329170002691X – ident: e_1_3_4_2_2 doi: 10.1186/s12916-017-0779-7 – ident: e_1_3_4_6_2 doi: 10.1016/S1474-4422(16)00130-7 – ident: e_1_3_4_9_2 doi: 10.1161/STROKEAHA.112.673384 – ident: e_1_3_4_17_2 doi: 10.1161/STROKEAHA.111.633586 – ident: e_1_3_4_5_2 doi: 10.1016/S1474-4422(09)70236-4 – volume: 1 start-page: 111 year: 1988 ident: e_1_3_4_10_2 article-title: The telephone interview for cognitive status. publication-title: Neuropsychiatry Neuropsychol Behav Neurol – ident: e_1_3_4_23_2 doi: 10.1161/STR.0b013e3182299496 – ident: e_1_3_4_7_2 doi: 10.1161/STROKEAHA.114.005842 – ident: e_1_3_4_15_2 doi: 10.1111/ijs.12092 – ident: e_1_3_4_20_2 doi: 10.1001/archneur.58.3.397 – ident: e_1_3_4_14_2 doi: 10.1159/000355496 – ident: e_1_3_4_19_2 doi: 10.1212/WNL.0b013e31820ce6a5 – ident: e_1_3_4_3_2 doi: 10.1371/journal.pone.0122864 – ident: e_1_3_4_22_2 doi: 10.1212/WNL.43.11.2412-a – ident: e_1_3_4_4_2 doi: 10.1161/CIRCRESAHA.116.308426 – ident: e_1_3_4_21_2 doi: 10.1017/S1355617716000199 – ident: e_1_3_4_12_2 doi: 10.1002/gps.1041 – ident: e_1_3_4_13_2 doi: 10.1161/01.STR.0000237236.88823.47 – ident: e_1_3_4_8_2 doi: 10.1161/STROKEAHA.114.004232 – ident: e_1_3_4_18_2 doi: 10.1159/000447057 |
SSID | ssj0002385 |
Score | 2.4894588 |
Snippet | BACKGROUND AND PURPOSE—Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone... Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2952 |
SubjectTerms | Aged Aged, 80 and over Cognition Cognitive Dysfunction - diagnosis Cognitive Dysfunction - etiology Follow-Up Studies Humans Interviews as Topic Middle Aged Prospective Studies Stroke - complications Stroke - therapy |
Title | Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29042492 https://www.proquest.com/docview/1952525597 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1tb9MwELbKkBAIId4G5U1G4tuU0SROk3wM3VBHFZBYNk18iZzEQVVLWnWtkPYP-RP8Fu5sx3HZeP0SVbZjt7mnd48vd2dCXsGX46DmuMMjFzYoHq-cWHDmuEHkcRbEwPExdzh9PxyfsHdnwVmv992KWtqsi_3y4sq8kv-RKrSBXDFL9h8kayaFBvgM8oUrSBiufyXjUyDRleF8SCEzsCIYba4jItu0lJEJEkJyuVF1mbuxKcarC-lGaMclpmLnXvKZT4FEgmrCaFP0CJtRGdbo0FmOozbH8kBF76lCJ-l0bt9wBNpnulLTytPJj9erxWwrHEm1yAJScTiwPBWfpgKLTivCfSpWxqBMFsvygs9UfGZjmlMMAngzMrmOc76ppp0VQo9JA0ZE9crD6_eSlY4y0H4QsK2u8YMIrbs95mCqra3cWWSD2LVVdaxK5162IUO0IcfZxw-Tw2Sc4GvtfVgvUKrdgtXyi8SVF-PrY3Wi30-1u9uua-S6B9sYPFrk4GhimALQpUCnc8Kir69aEotV60m2mdOl7dAtcvvrAiMszmcywcKiSdldckfvb2iiwHqP9ERzn9xIdQTHA_Ktwyxd1BQwSw0OqcEsdhnQUIVZCiCzxraYtcZ1mKUas7TFrDVKY1ZO12KWGsziyohZ64YOs1RiliqEPiQnbw-z0djRx4k4JcMgL15HZVy7GAdQwbMdDkNW1cDNCqDQPjxxYN6cYZXcsCp9IMYB4zGroyLkPjK40t8lOw38wMeEMl4MRFG6oOcihj6DWqBzp3b9sBrwSvSJ34oqL3WtfTzyZZ7LPffQzY2ssdp-rmTdJ465a6lqzfxh_MsWBTkYBXzTxxux2JznLmA7kM6CPnmk4GFmbOHUJ-4WXnKVeP3bFZ_8cran5Gb3p3xGdtarjXgOdH1dvJCY_wF4GO0Z |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+the+Telephone+Interview+of+Cognitive+Status+and+Telephone+Montreal+Cognitive+Assessment+Against+Detailed+Cognitive+Testing+and+Clinical+Diagnosis+of+Mild+Cognitive+Impairment+After+Stroke&rft.jtitle=Stroke+%281970%29&rft.au=Zietemann%2C+Vera&rft.au=Kopczak%2C+Anna&rft.au=M%C3%BCller%2C+Claudia&rft.au=Wollenweber%2C+Frank+Arne&rft.date=2017-11-01&rft.eissn=1524-4628&rft.volume=48&rft.issue=11&rft.spage=2952&rft_id=info:doi/10.1161%2FSTROKEAHA.117.017519&rft_id=info%3Apmid%2F29042492&rft.externalDocID=29042492 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon |